Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by New York Life Investment Management LLC

New York Life Investment Management LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.8% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 53,339 shares of the medical equipment provider's stock after acquiring an additional 6,069 shares during the period. New York Life Investment Management LLC's holdings in Intuitive Surgical were worth $27,841,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. M.E. Allison & CO. Inc. acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical in the 4th quarter worth $82,517,000. Sycomore Asset Management boosted its position in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after buying an additional 4,079 shares during the last quarter. Exome Asset Management LLC grew its stake in shares of Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after acquiring an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its position in shares of Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after acquiring an additional 525 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research note on Tuesday, November 26th. Barclays raised their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Leerink Partners upped their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Raymond James increased their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Finally, Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average price target of $613.10.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 2,401 shares of Intuitive Surgical stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at $205,093. The trade was a 87.18 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 269 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares of the company's stock, valued at $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 8,077 shares of company stock valued at $4,620,025 in the last ninety days. Company insiders own 0.90% of the company's stock.

Intuitive Surgical Stock Performance

Shares of ISRG traded up $9.38 during midday trading on Friday, hitting $573.15. 2,399,758 shares of the stock traded hands, compared to its average volume of 1,733,598. The business's 50 day moving average price is $569.87 and its two-hundred day moving average price is $528.64. The firm has a market capitalization of $204.14 billion, a PE ratio of 89.42, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.